WALSH DEINA H (Chief Financial Officer) purchased 114.3% of their position (8K shares) of BONE BIOLOGICS CORP on the open market
Open‑market purchase worth $5.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/14/2023ACC: 0001493152-23-032583
Officer· Chief Financial Officer
Since Jan 2022
+8K
Net shares
Net buyer
$5.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
8K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8K
Price / share
$0.64
Trade value
$5.12K
% of position
114.3%
9/13/2023
7K→15K
Total
Net shares
+8K
Net value
$5.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/13/2023 | P · Purchase | +8K | $0.64 | $5.12K | 114.3% | 7K | 15K |
| Total | +8K | $5.12K | ||||||
Derivative Transactions0
No derivative transactions reported